Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (151-160 of 229) with videos related to

Pageof 23
Sort By:
Ophthalmology|March 12, 2018
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular EdemaLee M Jampol, Adam R Glassman, Danni Liu, et al.
Ophthalmology|August 11, 2018
Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic RetinopathyJennifer K Sun, Adam R Glassman, Wesley T Beaulieu, et al.
Clinical Trials (London, England)|January 28, 2020
Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trialAdam R Glassman, Wesley T Beaulieu, Cynthia R Stockdale, et al.
Ophthalmology|September 25, 2012
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results, Michael J Elman, Haijing Qin, et al.
Immunity|August 2, 2015
A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3ζζMark S Lee, Caleb R Glassman, Neha R Deshpande, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 17, 2009
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulationNeil M Bressler, Allison R Edwards, Roy W Beck, et al.
Retina (Philadelphia, Pa.)|January 21, 2015
Topical nepafenec in eyes with noncentral diabetic macular edemaScott M Friedman, Talat H Almukhtar, Carl W Baker, et al.
Investigative Ophthalmology & Visual Science|November 8, 2012
Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomographyKakarla V Chalam, Susan B Bressler, Allison R Edwards, et al.
Ophthalmology|February 4, 2010
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edemaLloyd Paul Aiello, Allison R Edwards, Roy W Beck, et al.
JAMA Ophthalmology|January 25, 2019
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical TrialSusan B Bressler, Isoken Odia, Maureen G Maguire, et al.
Pageof 23

Showing results (151-160 of 229) with videos related to

Sort By:
Pageof 23
Ophthalmology|March 12, 2018
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular EdemaLee M Jampol, Adam R Glassman, Danni Liu, et al.
Ophthalmology|August 11, 2018
Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic RetinopathyJennifer K Sun, Adam R Glassman, Wesley T Beaulieu, et al.
Clinical Trials (London, England)|January 28, 2020
Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trialAdam R Glassman, Wesley T Beaulieu, Cynthia R Stockdale, et al.
Ophthalmology|September 25, 2012
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results, Michael J Elman, Haijing Qin, et al.
Immunity|August 2, 2015
A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3ζζMark S Lee, Caleb R Glassman, Neha R Deshpande, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 17, 2009
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulationNeil M Bressler, Allison R Edwards, Roy W Beck, et al.
Retina (Philadelphia, Pa.)|January 21, 2015
Topical nepafenec in eyes with noncentral diabetic macular edemaScott M Friedman, Talat H Almukhtar, Carl W Baker, et al.
Investigative Ophthalmology & Visual Science|November 8, 2012
Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomographyKakarla V Chalam, Susan B Bressler, Allison R Edwards, et al.
Ophthalmology|February 4, 2010
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edemaLloyd Paul Aiello, Allison R Edwards, Roy W Beck, et al.
JAMA Ophthalmology|January 25, 2019
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical TrialSusan B Bressler, Isoken Odia, Maureen G Maguire, et al.
Pageof 23